IONS · Ionis Pharmaceuticals
AI read · Bad for IONS
The AI's read
Lower expected TRYNGOLZA sales mean less income from the drug. The law firm's inquiry adds concern about what Ionis told investors, but it has not found that Ionis did anything wrong.
Kehoe Law Firm is looking into Ionis Pharmaceuticals after the company cut its sales forecast for TRYNGOLZA.
Bad for IONS
Ionis cut its 2026 TRYNGOLZA sales forecast, pointing to weaker product sales. A law firm is checking past disclosures, but it has not found wrongdoing.
Get alerts for IONS
Follow Ionis Pharmaceuticals (IONS) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for IONSFree on the App Store and Google Play, or on the web.